Brassica campestris Linn. var. rapa (L.) Hartm.
1. Taxonomic, Nomenclature & Therapeutic Summary Table
| Botanical Attribute | Pharmacognostic & Therapeutic Specification |
|---|---|
| Family | Cruciferae; Brassicaceae. |
| Habitat | Cultivated as an oil-yielding crop. |
| English | Field Mustard, Turnip Rape. |
| Ayurvedic | Sarshapa, Siddhaartha. |
| Unani | Sarson. |
| Siddha / Tamil | Kadugu. |
| Action | Stimulant, diuretic, emetic, rubefacient, counter-irritant. Used externally for bronchitis and rheumatic pains (increases flow of blood to a specific area). Powdered seeds are used as a tea for colds, influenza and fever. |
| Dosage | Seed—500 mg to 1 g paste. (API Vol. III.) |
| Taxonomic Cohort | Genus Brassica (5 documented species); Family Cruciferae (18 documented species). |
2. Classical Nomenclature, Taxonomy & Biogeographical Context
Brassica campestris rapa is an established medicinal plant species in Indian materia medica. It is classified under the botanical family Cruciferae; Brassicaceae (primary family classification: Cruciferae), placing it within a well-defined chemotaxonomic group of medicinal flora. Within botanical taxonomy, this taxon is cataloged directly under its primary accepted binomial without secondary botanical synonyms. Biogeographically, its documented habitat and ecological distribution span: Cultivated as an oil-yielding crop.
Across classical and vernacular Indian systems of medicine, Brassica campestris rapa is recognized under distinct polyglot nomenclature: in English botanical and trade usage as Field Mustard, Turnip Rape; in the Ayurvedic system (synchronized across The Ayurvedic Pharmacopoeia of India, CCRAS Standard Nomenclature, Sharangadhara Samhita, and Bhava Prakash) as Sarshapa, Siddhaartha; in the Unani-Tibb materia medica (recorded in The National Formulary of Unani Medicine and CCRUM literature) as Sarson; in the Siddha and Tamil medical tradition (compiled from the Formulary of Siddha Medicine and IMPCOPS Chennai) as Kadugu. Romanized Sanskrit and Ayurvedic spellings follow standard National Academy of Ayurveda (Rashtriya Ayurveda Vidyapeeth) transliteration conventions, using double vowels to preserve authentic classical pronunciation across regional medical traditions.
3. Therapeutic Actions, Phytochemistry & Pharmacological Profile
In therapeutic and clinical pharmacognosy, the primary recorded actions and clinical indications of Brassica campestris rapa are: Stimulant, diuretic, emetic, rubefacient, counter-irritant. Used externally for bronchitis and rheumatic pains (increases flow of blood to a specific area). Powdered seeds are used as a tea for colds, influenza and fever. These traditional and clinical attributes reflect the plant part-specific pharmacological profile documented across classical Indian treatises and modern herbal pharmacopoeias.
Experimental phytochemistry, active chemical constituents, and pharmacological screening studies reported for Brassica campestris rapa establish the following evidence base: The seeds contain glycosinolates (the derivatives are responsible for toxicity). The concentration of the major glucosinolate, gluco-napin, varies from 0.64 to 1.8% in the oil-free meal of Indian brassicas. The glucosinolates in rapeseed meal split upon enzymatic hydrolysis to produce glucose, potassium, hydrogen sulphate and a sulphurcontaining compound which undergoes intramolecular rearrangement to give rise to the antinutritional factors, isothiocyanates or thiocyanates. The volatile oil of mustard is given internally in colic; in overdoses it is highly poisonous and produces gastroenteric inflammations. It is employed externally as a liniment for rheumatic pains. Adulteration of mustard oil with argemone oil (Argemone mexicana is frequently found growing in brassica fields), by accident or by design, has led to the widespread epidemics of dropsy and glaucoma due to an alkaloid sanguinarine. Black mustard contains sinigrin, which on hydrolysis by enzyme myrosin, produces allyisothiocynate; the white mustard contains sinalbin, which produces p-hydroxybenzyl isothiocynate. Mucilage contains sinapine.

Botanical Reference 1: Brassica rapa — Botanical specimen

Botanical Reference 2: Brassica rapa — Botanical specimen

Botanical Reference 3: Brassica campestris — Wikimedia Commons reference
4. Comparative Genus & Family Pharmacognosy
Taxonomically, the genus Brassica comprises 5 distinct medicinal species in Indian herbal literature. Closely allied congeneric species include: Brassica alba (Action: Stimulant to gastric mucosa, increases pancreatic secretions; emetic (used in…); Brassica juncea (Action: Raai is a substitute for Mustard. Antidysenteric, stomachic, diaphoretic…); Brassica napus (Action: Emollient, diuretic, anticatarrhal); Brassica nigra (Action: Seeds are used for treating coryza with thin excoriating discharge with…). Comparing Brassica campestris rapa alongside its congeners in genus Brassica highlights both shared secondary metabolite classes and species-specific organotropism across different ecological zones.
At the family level, Cruciferae encompasses 18 documented medicinal species (0.99% of the 1,814-species flora). Other representative medicinal members of Cruciferae include: Anastatica hierochuntica Linn. (Jericho Rose), Armoracia lapathifolia (Horseradish), Brassica alba (Siddhaartha), Brassica juncea (Raajikaa), Capsella bursa-pastoris (Shepherd’s Purse). In comparative pharmacognosy, evaluating species within the same botanical family aids quality control, authentication of crude drugs, and identification of chemotaxonomic markers.

Figure 1: Quantitative documentation profile across all 18 medicinal species of family Cruciferae.
5. Pharmacopoeial Standards, Posology & Reference Framework
For clinical and traditional dispensing, the standardized posology and crude herb dosage for Brassica campestris rapa are prescribed as follows: Seed—500 mg to 1 g paste. (API Vol. III.). Crude drug dosages are calibrated against The Ayurvedic Pharmacopoeia of India (Vols. I–IV) and the Standard Nomenclature of Ayurvedic Medicinal Plants published by the Central Council for Research in Ayurveda and Siddha (CCRAS). Classical and modern pharmacognostic synchronization for Brassica campestris rapa integrates standards from The Ayurvedic Pharmacopoeia of India, The National Formulary of Unani Medicine, Formulary of Siddha Medicine, The Wealth of India (CSIR), Compendium of Indian Medicinal Plants (CDRI), Dictionary of Indian Medicinal Plants (CIMAP), German Commission E, ESCOP, WHO monographs, British Herbal Pharmacopoeia, and Natural Medicines Comprehensive Database.